Cargando…
Towards a Molecular Understanding of the Link between Imatinib Resistance and Kinase Conformational Dynamics
Due to its inhibition of the Abl kinase domain in the BCR-ABL fusion protein, imatinib is strikingly effective in the initial stage of chronic myeloid leukemia with more than 90% of the patients showing complete remission. However, as in the case of most targeted anti-cancer therapies, the emergence...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659586/ https://www.ncbi.nlm.nih.gov/pubmed/26606374 http://dx.doi.org/10.1371/journal.pcbi.1004578 |